Evidence map›Paper›PMID 40260271›Full record

ArticleAfrican journal of thoracic and critical care medicine2025

Feasibility and safety of transbronchial lung cryobiopsy and mediastinal lymph node cryobiopsy: Experience from a resource limited African setting.

A Esmail, K Tsoka, R Hofmeyr, J Chokoe Maluleke, H Donson, R Roberts, T Pennell, N Vorajee, M Emhemed, S Eknewir and 2 more

Abstract read
In one paragraph

Article in African journal of thoracic and critical care medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Resources in the bronchoscopy suite and the utility of cryobiopsy.African journal of thoracic and critical care medicine · 2025
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

A EsmailContributed equally; names listed in order of seniority.ORCID https://orcid.org/0000-0002-1835-9252
K TsokaContributed equally; names listed in order of seniority.
R HofmeyrDepartment of Anaesthesia and Perioperative Medicine, Faculty of Health Sciences, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa.ORCID https://orcid.org/0000-0002-9990-7459
J Chokoe MalulekeContributed equally; names listed in order of seniority.ORCID https://orcid.org/0000-0001-7017-7424
H DonsonCentre for Lung Infection and Immunity, Division of Pulmonology, Department of Medicine, Faculty of Health Sciences, University of Cape Town; University of Cape Town Lung Institute; SAMRC Centre for the Study of Antimicrobial Resistance, University of Cape Town, South Africa.
R RobertsContributed equally; names listed in order of seniority.
T PennellNational Health Laboratory Service, Groote Schuur Hospital, Cape Town, South Africa.
N VorajeeCentre for Lung Infection and Immunity, Division of Pulmonology, Department of Medicine, Faculty of Health Sciences, University of Cape Town; University of Cape Town Lung Institute; SAMRC Centre for the Study of Antimicrobial Resistance, University of Cape Town, South Africa.
M EmhemedCentre for Lung Infection and Immunity, Division of Pulmonology, Department of Medicine, Faculty of Health Sciences, University of Cape Town; University of Cape Town Lung Institute; SAMRC Centre for the Study of Antimicrobial Resistance, University of Cape Town, South Africa.
S EknewirCentre for Lung Infection and Immunity, Division of Pulmonology, Department of Medicine, Faculty of Health Sciences, University of Cape Town; University of Cape Town Lung Institute; SAMRC Centre for the Study of Antimicrobial Resistance, University of Cape Town, South Africa.
B MbenaCentre for Lung Infection and Immunity, Division of Pulmonology, Department of Medicine, Faculty of Health Sciences, University of Cape Town; University of Cape Town Lung Institute; SAMRC Centre for the Study of Antimicrobial Resistance, University of Cape Town, South Africa.
K DhedaCentre for Lung Infection and Immunity, Division of Pulmonology, Department of Medicine, Faculty of Health Sciences, University of Cape Town; University of Cape Town Lung Institute; SAMRC Centre for the Study of Antimicrobial Resistance, University of Cape Town, South Africa.ORCID https://orcid.org/0000-0001-7709-5341

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Transbronchial lung cryobiopsy (TBLC) is a relatively new technique recommended for sampling of lung parenchyma in patients with suspected interstitial lung disease (ILD) and as an alternative to surgical lung biopsy. A more recently introduced technique is endobronchial ultrasound-guided transbronchial mediastinal lymph node lymph node cryobiopsy (EBUS-TMC) to enable tissue biopsy of mediastinal lymph nodes. However, there are no data on the feasibility of implementing these techniques in a resource-limited African setting, where there is a chronic bed shortage and same-day discharges are preferable. Objectives: To determine the feasibility and diagnostic yield of TBLC and EBUS-TMC in a resource-limited African setting. Methods: We performed an audit of lung and lymph node cryobiopsy procedures performed at the E16 Respiratory Clinic at Groote Schuur Hospital, Cape Town, South Africa. Indications, diagnostic performance outcomes and lessons learned were documented and analysed. Results: Sixteen patients underwent 19 cryobiopsy procedures that were performed under general anaesthesia (n=11 TBLC, n=8 EBUS TMC, including 3 patients in whom both TBLC and EBUS-TMC were concurrently performed). The main indications were evaluation of ILD and suspected lymph node malignancy. The diagnostic yield was 63.6% for TBLC (n=7/11; 2 nonspecific interstitial pneumonia, 2 sarcoidosis, 1 espiratory bronchiolitis-ILD, 1 organising pneumonia, 1 nonspecific chronic inflammation) and 50.0% for EBUS-TMC (n=4/8; 1 plasmacytoma, 1 lymphoma, 1 cryptococcus infection, 1 patient with both cryptococcus infection and tuberculosis). Of the patients, 2 had moderate bleeding and 3 had mild bleeding, and 14 were discharged on the day of the procedure. Conclusion: TBLC and EBUS-TMC, with avoidance of surgical lung biopsy in most patients and same-day discharge in most patients, are feasible in an African setting. These data inform clinical practice and programme implementation in resource-limited settings. Study synopsis:

Indexed as

endobronchial ultrasound-guided transbronchial mediastinal lymph node cryobiopsy (EBUS-TMC)interstitial lung disease (ILD)interventional pulmonologyTransbronchial lung cryobiopsy (TBLC)

Identifiers

PMID40260271
PMCPMC12009498

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.